Stress management versus lifestyle modification on systolic hypertension and medication elimination: A randomized trial

Journal of Alternative and Complementary Medicine

Volumn 14, Issue 2, 2008, Pages 129-138

  Dusek, Jeffery A ^a,b,c,f   Hibberd, Patricia L ^a,d   Buczynski, Beverly ^a   Chang, Bei Hung ^a,e   Dusek, Kathryn C ^a,b   Johnston, Jennifer M ^a,b   Wohlhueter, Ann L ^a,b   Benson, Herbert ^a,b,c,d   Zusman, Randall M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Mind/Body Medical Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY   (United States)

^f ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS MANAGEMENT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PERSONAL SATISFACTION; RELAXATION TECHNIQUES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 40549088903     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2007.0623     Document Type: Article

References (35)

1. NHANES III Data Files. Online document at: www.cdc.gov/nchs/about/major/ nhanes/nh3data.htm Accessed August 10, 2007.
2. NHANES 2003-2004. Online document at: www.cdc.gov/nchs/about/major/ nhanes/nhanes2003-2004/nhanes03_04.htm Accessed August 10, 2007.
3. Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care 2001;39:599-615.
4. Franklin SS, Gustin WT, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation 1997;96:308-315.
5. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572.
6. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
7. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000;355:865-872.
8. Nuesch R, Schroeder K, Dieterle T, et al. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: A prospective case-control study. BMJ 2001;323:142-146.
9. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-974.
10. Ross SD, Akhras KS, Zhang S, et al. Discontinuation of antihypertensive drugs due to adverse events: A systematic review and meta-analysis. Pharmacotherapy 2001;21:940-953.
11. Chen K, Chiou CF, Plauschinat CA, et al. Patient satisfaction with antihypertensive therapy. J Hum Hypertens 2005;19:793-799.
12. Gurwitz JH. Polypharmacy: A new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004;164:1957-1959.
13. Beary JF, Benson H. A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response. Psychosom Med 1974;36:115-120.
14. Benson H, Rosner BA, Marzetta BR, et al. Decreased blood-pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet 1974;1:289-291.
15. Leserman J, Stuart E, Mamish M, et al. Nonpharmacologic intervention for hypertension: Long term follow up. J Cardiopulmonary Rehabil 1989;9:316-324.
16. Schneider RH, Staggers F, Alexander CN, et al. A randomised controlled trial of stress reduction for hypertension in older African Americans. Hypertension 1995;26:820-827.
17. Schneider RH, Alexander CN, Staggers F, et al. A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year. Am J Hypertens 2005;18:88-98.
18. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol 1971;221:795-799.
19. Dusek JA, Chang BH, Zaki J, et al. Association between oxygen consumption and nitric oxide production during the relaxation response. Med Sci Monit 2006;12:CR1-CR10.
20. Hoffman JW, Benson H, Arns PA, et al. Reduced sympathetic nervous system responsivity associated with the relaxation response. Science 1982;215:190-192.
21. Kalish LA, Buczynski B, Connell P, et al. Stop Hypertension with the Acupuncture Research Program (SHARP): Clinical trial design and screening results. Control Clin Trials 2004;25:76-103.
22. Shaw LJ, Berman DS, Hendel RC, et al. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol 2006;97:1538-1544.
23. Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA 2003;289:2083-2093.
24. Moore TJ, Conlin PR, Ard J, et al. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 2001;38:155-158.
25. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
26. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-764.
27. Forte P, Copland M, Smith LM, et al. Basal nitric oxide synthesis in essential hypertension. Lancet 1997;349:837-842.
28. Vita JA. Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol 2002;359:186-200.
29. Napoli C, Ignarro LJ. Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol 2003;43:97-123.
30. Black HR, Elliott WJ, Weber MA, et al. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension 2001;38:1118-1123.
31. Grimm RH Jr., Black H, Rowen R, et al. Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension. Am J Hypertens 2002;15:31-36.
32. Ferrier KE, Waddell TK, Gatzka CD, et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension 2001;38:222-226.
33. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-223.
34. Prevalence of actions to control high blood pressure - 20 states, 2005. MMWR Morb Mortal Wkly Rep 2007;56:420-423.
35. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685-1697.